Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360705 · ClinicalTrials.gov registry record · NA
StrataMGT for the Treatment of Vulvar Lichen Sclerosus
A NA study, sponsored by Center for Vulvovaginal Disorders.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06360705: Completed NA study, sponsored by Center for Vulvovaginal Disorders.
NCT06360705 is a NA study that has completed, run by Center for Vulvovaginal Disorders. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06360705, a NA study, has completed, sponsored by Center for Vulvovaginal Disorders.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy and safety of StrataMGT for the treatment of vulvar lichen sclerosus.
Primary Outcome
Histopathologic inflammation that occurs with lichen sclerosus will be assessed by a dermatopathologist on 4mm punch biopsies performed during the screening visit (Week 0) and at the Week 10 visit using the following clinical scoring scale. The scale is from 0-3, 0 being no disease of inflammation and 3 being severe disease or inflammation.
Interventions
- DEVICE StrataMGT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT06360705 record still lists
NCT06360705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which StrataMGT is the first listed.
NCT06360705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06360705 about?
NCT06360705 is a clinical study titled "StrataMGT for the Treatment of Vulvar Lichen Sclerosus". This study is designed to evaluate the efficacy and safety of StrataMGT for the treatment of vulvar lichen sclerosus.
What is the current status of trial NCT06360705?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2024-04-16. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT06360705?
The interventions under investigation include: StrataMGT (DEVICE).
Who is sponsoring clinical trial NCT06360705?
This trial is sponsored by Center for Vulvovaginal Disorders, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06360705's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI